...
首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Development and external validation of a predictive model for pathological complete response of rectal cancer patients including sequential PET-CT imaging.
【24h】

Development and external validation of a predictive model for pathological complete response of rectal cancer patients including sequential PET-CT imaging.

机译:直肠癌患者病理完全缓解的预测模型的开发和外部验证,包括顺序PET-CT成像。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To develop and validate an accurate predictive model and a nomogram for pathologic complete response (pCR) after chemoradiotherapy (CRT) for rectal cancer based on clinical and sequential PET-CT data. Accurate prediction could enable more individualised surgical approaches, including less extensive resection or even a wait-and-see policy. METHODS AND MATERIALS: Population based databases from 953 patients were collected from four different institutes and divided into three groups: clinical factors (training: 677 patients, validation: 85 patients), pre-CRT PET-CT (training: 114 patients, validation: 37 patients) and post-CRT PET-CT (training: 107 patients, validation: 55 patients). A pCR was defined as ypT0N0 reported by pathology after surgery. The data were analysed using a linear multivariate classification model (support vector machine), and the model's performance was evaluated using the area under the curve (AUC) of the receiver operating characteristic (ROC) curve. RESULTS: The occurrence rate of pCR in the datasets was between 15% and 31%. The model based on clinical variables (AUC(train)=0.61+/-0.03, AUC(validation)=0.69+/-0.08) resulted in the following predictors: cT- and cN-stage and tumour length. Addition of pre-CRT PET data did not result in a significantly higher performance (AUC(train)=0.68+/-0.08, AUC(validation)=0.68+/-0.10) and revealed maximal radioactive isotope uptake (SUV(max)) and tumour location as extra predictors. The best model achieved was based on the addition of post-CRT PET-data (AUC(train)=0.83+/-0.05, AUC(validation)=0.86+/-0.05) and included the following predictors: tumour length, post-CRT SUV(max) and relative change of SUV(max). This model performed significantly better than the clinical model (p(train)<0.001, p(validation)=0.056). CONCLUSIONS: The model and the nomogram developed based on clinical and sequential PET-CT data can accurately predict pCR, and can be used as a decision support tool for surgery after prospective validation.
机译:目的:根据临床和循序的PET-CT数据,开发和验证直肠癌放化疗(CRT)后病理完全缓解(pCR)的准确预测模型和诺模图。准确的预测可以启用更多个性化的手术方法,包括较少的切除术,甚至采取观望策略。方法和材料:从四个不同的机构收集了来自953例患者的基于人群的数据库,并将其分为三类:临床因素(培训:677例患者,验证:85例患者),CRT前PET-CT(培训:114例患者,验证: 37位患者)和CRT后的PET-CT(培训:107位患者,验证:55位患者)。 pCR定义为手术后病理报告的ypT0N0。使用线性多元分类模型(支持向量机)分析数据,并使用接收器工作特性(ROC)曲线的曲线下面积(AUC)评估模型的性能。结果:pCR在数据集中的发生率在15%至31%之间。基于临床变量(AUC(序列)= 0.61 +/- 0.03,AUC(验证)= 0.69 +/- 0.08)的模型得出以下预测因子:cT-阶段和cN-阶段以及肿瘤长度。 CRT之前的PET数据的添加并未导致显着更高的性能(AUC(火车)= 0.68 +/- 0.08,AUC(验证)= 0.68 +/- 0.10),并且显示出最大的放射性同位素吸收(SUV(max))和肿瘤位置作为额外的预测因子。达到的最佳模型基于CRT后的PET数据(AUC(序列)= 0.83 +/- 0.05,AUC(验证)= 0.86 +/- 0.05),并包括以下预测因子:肿瘤长度, CRT SUV(max)和SUV(max)的相对变化。该模型的表现明显优于临床模型(p(train)<0.001,p(validation)= 0.056)。结论:基于临床和顺序PET-CT数据开发的模型和列线图可以准确预测pCR,并且可以在前瞻性验证后用作手术的决策支持工具。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号